Type 2 diabetes and risk of hospital admission or death for chronic liver diseases

Journal of Hepatology

Volumn 64, Issue 6, 2016, Pages 1358-1364

  Wild, Sarah H ^a   Morling, Joanne R ^a   McAllister, David A ^a   Kerssens, Jan ^b   Fischbacher, Colin ^b   Parkes, Julie ^c   Roderick, Paul J ^d   Sattar, Naveed ^e   Byrne, Christopher D ^c,f  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b INFORMATION SERVICES DIVISION   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

^f UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cohort; Diabetes; Liver disease

Indexed keywords

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; AUTOIMMUNE LIVER DISEASE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; FEMALE; HEMOCHROMATOSIS; HEPATITIS VIRUS; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX; SOCIAL STATUS; VIRUS HEPATITIS; CHRONIC DISEASE; COMPLICATION; HOSPITALIZATION; LIVER DISEASE; MIDDLE AGED; MORTALITY; RISK; SOCIAL CLASS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HOSPITALIZATION; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RETROSPECTIVE STUDIES; RISK; SOCIAL CLASS;

EID: 84962439762     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2016.01.014     Document Type: Article

References (30)

1. R. Williams, R. Aspinall, M. Bellis, G. Camps-Walsh, M. Cramp, A. Dhawan, and et al. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis Lancet 384 2014 1953 1997
2. Y. Kim, A. Ejaz, A. Tayal, G. Spolverato, J.F. Bridges, R.A. Anders, and et al. Temporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years Cancer 120 2014 3058 3065
3. A.A. Mokdad, A.D. Lopez, S. Shahraz, R. Lozano, A.H. Mokdad, J. Stanaway, and et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis BMC Med 12 2014 145
4. N.G. Ladep, S.A. Khan, M.M. Crossey, A.V. Thillainayagam, S.D. Taylor-Robinson, and M.B. Toledano Incidence and mortality of primary liver cancer in England and Wales: changing patterns and ethnic variations World J Gastroenterol 20 2014 1544 1553
5. A.F. Peery, E.S. Dellon, J. Lund, S.D. Crockett, C.E. McGowan, W.J. Bulsiewicz, and et al. Burden of gastrointestinal disease in the United States: 2012 update Gastroenterology 143 2012 1179 1187
6. K.C. Sung, W.S. Jeong, S.H. Wild, and C.D. Byrne Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes Diabetes Care 35 2012 717 722
7. K.C. Sung, S.H. Wild, and C.D. Byrne Resolution of fatty liver and risk of incident diabetes J Clin Endocrinol Metab 98 2013 3637 3643
8. C. Wang, X. Wang, G. Gong, Q. Ben, W. Qiu, Y. Chen, and et al. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies Int J Cancer 130 2012 1639 1648
9. J.J. Walker, D.H. Brewster, H.M. Colhoun, C.M. Fischbacher, G.P. Leese, R.S. Lindsay, and et al. Type 2 diabetes, socioeconomic status and risk of cancer in Scotland 2001-2007 Diabetologia 56 2013 1712 1715
10. L. Guariguata, D.R. Whiting, I. Hambleton, J. Beagley, U. Linnenkamp, and J.E. Shaw Global estimates of diabetes prevalence for 2013 and projections for 2035 Diabetes Res Clin Pract 103 2014 137 149
11. J.J. Walker, S.J. Livingstone, H.M. Colhoun, R.S. Lindsay, J.A. McKnight, A.D. Morris, and et al. Effect of socioeconomic status on mortality among people with type 2 diabetes: a study from the Scottish Diabetes Research Network Epidemiology Group Diabetes Care 34 2011 1127 1132
12. K. Chartier, and R. Caetano Ethnicity and health disparities in alcohol research Alcohol Res Health 33 2010 152 160
13. P. Makela Alcohol-related mortality as a function of socio-economic status Addiction 94 1999 867 886
14. J. Konfortion, V.H. Coupland, H.M. Kocher, W. Allum, M.J. Grocock, and R.H. Jack Time and deprivation trends in incidence of primary liver cancer subtypes in England J Eval Clin Pract 4 2014 498 504
15. C.A. Jackson, N.R. Jones, J.J. Walker, C.M. Fischbacher, H.M. Colhoun, G.P. Leese, and et al. Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in Scotland Diabetologia 55 2012 2938 2945
16. J. Guy, and H.F. Yee Jr. Health disparities in liver disease: Time to take notice and take action Hepatology 50 2009 309 313
17. G.C. Nguyen, and P.J. Thuluvath Racial disparity in liver disease: Biological, cultural, or socioeconomic factors Hepatology 47 2008 1058 1066
18. H. Anwar, C.M. Fischbacher, G.P. Leese, R.S. Lindsay, J.A. McKnight, and S.H. Wild Assessment of the under-reporting of diabetes in hospital admission data: a study from the Scottish Diabetes Research Network Epidemiology Group Diabet Med 28 2011 1514 1519
19. S.J. Livingstone, H.C. Looker, E.J. Hothersall, S.H. Wild, R.S. Lindsay, J. Chalmers, and et al. Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study PLoS Med 9 2012 e1001321
20. W.S. Yang, P. Va, F. Bray, S. Gao, J. Gao, H.L. Li, and et al. The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies PLoS ONE 6 2011 e27326
21. S.C. Gordon, P.J. Pockros, N.A. Terrault, R.S. Hoop, A. Buikema, D. Nerenz, and et al. Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection Hepatology 56 2012 1651 1660
22. P. Scarborough, P. Bhatnagar, K.K. Wickramasinghe, S. Allender, C. Foster, and M. Rayner The economic burden of ill health due to diet, physical inactivity, smoking, alcohol and obesity in the UK: an update to 2006-07 NHS costs J Public Health (Oxf) 33 2011 527 535
23. J. Logue, J.J. Walker, G. Leese, R. Lindsay, J. McKnight, A. Morris, and et al. Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality Diabetes Care 36 2013 887 893
24. R. Lawder, O. Harding, D. Stockton, C. Fischbacher, D.H. Brewster, J. Chalmers, and et al. Is the Scottish population living dangerously? Prevalence of multiple risk factors: the Scottish Health Survey 2003 BMC Public Health 10 2010 330
25. C.L. Hart, D.S. Morrison, G.D. Batty, R.J. Mitchell, and Smith G. Davey Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies BMJ 11 2010 c1240
26. N. Sattar, and J.M. Gill Type 2 diabetes as a disease of ectopic fat? BMC Med 12 2014 123
27. M. Ekstedt, H. Hagstrom, P. Nasr, M. Fredrikson, P. Stal, S. Kechagias, and et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up Hepatology 61 2014 1547 1554
28. C.D. Byrne, and G. Targher NAFLD: a multisystem disease J Hepatol 62 2015 S47 S64
29. J. Adams, and M. White Removing the health domain from the Index of Multiple Deprivation 2004-effect on measured inequalities in census measure of health J Public Health (Oxf) 28 2006 379 383
30. S.K. Asrani, J.J. Larson, B. Yawn, T.M. Therneau, and W.R. Kim Underestimation of liver-related mortality in the United States Gastroenterology 145 2013 375 382